Brain Resource
Brain Resource (ASX: BRC) has established the first and largest international human brain database to make sense of the brain's complexities and provide a coherent model for measuring brain health.
Brain Resource shares soar 26.83% as company targets multi-billion dollar ADHD market
Wednesday, February 22, 2012 by Angela Kean
Brain Resource (ASX: BRC) is a favourite with investors today with shares gaining 26.83% to A$0.26.
The company had a stellar start to 2012 with around A$13.6 million in cash reserves after receiving $4 million in equity funding during the December 2011 quarter.
Brain Resource’s 50/50 joint venture, BRC Focus, issued Malta Trading Platform, an investment vehicle controlled by Och-Ziff Capital Management Group, 4 million Exchangeable Convertible Preference Shares at $1 each in exchange for the funding.
BRC Focus was formed by Brain Resource and a subsidiary of Och-Ziff Capital Management Group to tackle the multi-billion dollar Attention Deficit Hyperactivity Disorder (ADHD) market.
ADHD is the most commonly diagnosed disorder of childhood, impacting more than 5 million children, or 9%, in the U.S.
GlobalData estimates that the global ADHD therapeutics market was valued at $3.8 billion in 2010.
BRC Focus is developing a website that leverages off current Brain Resource products to bring together information, objective assessment and solutions, including Brain Training, for the key issues facing children and parents with ADHD.
Brain Resource has agreed to provide the joint venture with a perpetual licence to its relevant platform content for exclusive use in the ADHD parent market.
No investment advice
The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
